Nasdaq
TCRX
TScan Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- −2.2%
- 1 month
- −28.7%
- 1 year
- −55.9%
$0.7632 · Mkt cap $49.9M
At the 6 Aug 2026 close
Nasdaq
TScan Therapeutics, Inc.
$0.7632 · Mkt cap $49.9M
At the 6 Aug 2026 close
TScan Therapeutics, Inc. trades under the ticker TCRX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $49.9M. The last closing price was $0.7632, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −55.9%, and −28.7% over the past month. Returns are price returns and exclude dividends.
This page exists because TCRX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.